FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
AnteoTech Limited Stock AnalysisComprehensive stock analysis for AnteoTech Limited (ADO.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisADO.AX
ADO.AX
AnteoTech Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ADO.AX
Home🔹Stocks🔹AnteoTech Limited

AnteoTech Limited

ADO.AX•ASX

AnteoTech Limited

ADO.AX•ASX
Sentiment

Your view on ADO.AX

Sentiment
Your view
ADO.AX
AnteoTech Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ADO.AX
Company Overview

Overview

What the company does, where it operates, and who runs it.

About AnteoTech Limited

Industry
Chemicals - Specialty
Sector
Basic Materials
CEO
Merrill Gray
Headquarters
Brisbane Technology Park, Eight Mile Plains, QLD, AU
Industry
Chemicals - Specialty
Sector
Basic Materials
CEO
Merrill Gray
Headquarters
Brisbane Technology Park, Eight Mile Plains, QLD, AU
Description

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company’s products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit, a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development, and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation. It also provides AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries. In addition, the company offers contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

FRC's fair value estimate for AnteoTech Limited, and the rating behind it. ADO.AX last traded at AUD 0.02; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for AnteoTech Limited. Starting points for AnteoTech Limited: beta 1.08 — an Chemicals - Specialty name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for AnteoTech Limited. AnteoTech Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for AnteoTech Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for AnteoTech Limited. AnteoTech Limited has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

AnteoTech Limited valued side by side against its closest peers. AnteoTech Limited is measured against Chemicals - Specialty peers within the Basic Materials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Which institutions hold AnteoTech Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

Buying and selling by AnteoTech Limited executives and directors. Shares of AnteoTech Limited have traded between AUD 0.01 and AUD 0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming AnteoTech Limited. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming AnteoTech Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

Latest headlines and company announcements for AnteoTech Limited. Coverage tracks AnteoTech Limited within Chemicals - Specialty (Basic Materials). Press releases and market coverage, newest first.

Peer companies

  • AGN.AX — Argenica Therapeutics Ltd
  • CYP.AX — Cynata Therapeutics Limited
  • EYE.AX — Nova Eye Medical Limited
  • IIQ.AX — INOVIQ Ltd
  • NOX.AX — Noxopharm Limited
  • NSB.AX — NeuroScientific Biopharmaceuticals Limited
  • PIQ.AX — Proteomics International Laboratories Ltd.

More Chemicals - Specialty companies

  • COIHY — Croda International Plc
  • COOSF — Carbios SAS
  • COVTY — Covestro AG
  • COWI — CarbonMeta Technologies, Inc.
  • CRKN — Crown ElectroKinetics Corp.
  • CSNVF — Corbion N.V.
  • CSNVY — Corbion N.V.
  • CUYRF — C.Uyemura & Co.,Ltd.

News

Latest Market News